Literature DB >> 26856639

Storage duration of transfused red blood cells is not significantly associated with postoperative adverse events in pediatric cardiac surgery patients.

Hirokazu Kawase1, Moritoki Egi2, Tomoyuki Kanazawa1, Kazuyoshi Shimizu1, Yuichiro Toda3, Tatsuo Iwasaki1, Kiyoshi Morita1.   

Abstract

The aim of this study was to evaluate the association of storage duration of transfused red blood cells with the risk of postoperative serious adverse events in pediatric cardiac surgery patients. We studied 517 patients and found that 22 patients (4.3%) had at least one serious adverse event. The maximum and mean storage duration of transfused red blood cells did not differ significantly between patients with and without serious adverse events (maximum, p = 0.89; mean, p = 0.81). In our study of pediatric cardiac surgery patients, the storage duration of transfused red blood cells was not significantly associated with the risk of serious adverse events.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pediatric cardiac patients; Red blood cell; Storage duration; Transfusion

Mesh:

Year:  2016        PMID: 26856639     DOI: 10.1016/j.transci.2016.01.027

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  2 in total

Review 1.  Red blood cell storage time and transfusion: current practice, concerns and future perspectives.

Authors:  María García-Roa; María Del Carmen Vicente-Ayuso; Alejandro M Bobes; Alexandra C Pedraza; Ataúlfo González-Fernández; María Paz Martín; Isabel Sáez; Jerard Seghatchian; Laura Gutiérrez
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

2.  Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Jill M Cholette; Ariane Willems; Stacey L Valentine; Scot T Bateman; Steven M Schwartz
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.